Beltran Lab Videos


​Prostate-Specific Membrane Antigen (PSMA)

Dr. Beltran provided her insights on the use of PSMA as an imaging tool and therapeutic target in prostate cancer. She discussed our collaborative work with Drs. Scott Tagawa and Neil Bander at Weill Cornell Medicine supported by a Department of Defense Prostate Cancer Research Program Award! 
Neuroendocrine Prostate Cancer
​
Dr. Beltran shared her research at the DoD Prostate Cancer Research Program ​IMPACT meeting (2016).  Genomic and epigenomic approaches to understand how and why some prostate cancer patients develop an aggressive neuroendocrine phenotype after therapy. ​

​
NEPC Organoids

We are using state-of-art technologies to develop three-dimension organoid model systems to investigate neuroendocrine prostate cancer progression. NEPC cells here express synaptophysin (green) protein, which is a classical neuroendocrine marker. Cellular nuclei are shown in blue.    


Organoid Growth

We use advanced imaging tools to characterize tumor organoid growth and study how new treatments impact tumor cell phenotype and proliferation.
Picture

​Here are videos from the 2022 and 2023 Prostate Cancer Foundation Scientific Retreats describing some of our lab's research

https://www.pcf.org/scientific-retreat/29th-annual/29th-annual-scientific-retreat-video-replays/session-3-neuroendocrine-prostate-cancer/

https://www.pcf.org/scientific-retreat/30th-annual/session-2-treatment-resistance-and-plasticity-2023/